SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign substances that can make us ill. These proteins circulate in the bloodstream and ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that fuels tumor ...

Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Antibodies touch nearly every corner of healthcare. These carefully crafted proteins can target cancer cells, control autoimmune diseases, fight infections, and destroy the toxic proteins that drive ...

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed antibody in the clinic. But the industry is divided on what “AI-designed” really ...

You may not realize it, but being able to produce tears and saliva is a gift because they help protect our eyes and mouths from infections. However, those with Sjogren's Disease are unable to produce ...

New research presented at the American College of Rheumatology (ACR) annual meeting contributed to the growing body of evidence highlighting the elevated risks of non-Hodgkin lymphoma and other ...

Image of antibodies created from scratch. (UW Institute for Protein Design / Ian C. Haydon Graphic) Researchers from Nobel Laureate David Baker’s lab and the University of Washington’s Institute for ...